应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
BOLD Boundless Bio, Inc.
交易中 05-09 15:25:16 EDT
9.16
-0.74
-7.47%
最高
10.36
最低
9.08
成交量
8.34万
今开
9.66
昨收
9.90
日振幅
12.93%
总市值
2.04亿
流通市值
5,725万
总股本
2,224万
成交额
79.71万
换手率
1.33%
流通股本
625.00万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Boundless Bio(BOLD.US)获Piper Sandler首次覆盖,给予增持评级, 目标价20.00美元。
智通财经 · 04-22
Boundless Bio(BOLD.US)获Piper Sandler首次覆盖,给予增持评级, 目标价20.00美元。
肿瘤生物技术公司Boundless Bio(BOLD.US)IPO定价16美元/股 今晚登陆纳斯达克
智通财经 · 03-28
肿瘤生物技术公司Boundless Bio(BOLD.US)IPO定价16美元/股 今晚登陆纳斯达克
拜耳支持的制药商Boundless Bio通过IPO筹集1亿美元-36氪
界面 · 03-28
拜耳支持的制药商Boundless Bio通过IPO筹集1亿美元-36氪
加载更多
公司概况
公司名称:
Boundless Bio, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Boundless Bio, Inc.最初成立于2018年4月10日,原名Pretzel Therapeutics, Inc.,是一家特拉华州公司。2019年7月8日,公司更名为Boundless Bio, Inc.。他们是一家临床阶段的肿瘤学公司,致力于开启癌症治疗的新方式,通过靶向染色体外DNA(ecDNA)来解决癌基因扩增肿瘤患者的显著未满足需求,在超过14%的癌症患者中观察到癌基因扩增的根本原因。他们的使命是成为领先的生物制药公司,利用ecDNA生物学提供变革性的治疗方法,改善和延长患有先前难治性癌基因扩增癌的患者的生命。
发行价格:
--
{"stockData":{"symbol":"BOLD","market":"US","secType":"STK","nameCN":"Boundless Bio, Inc.","latestPrice":9.16,"timestamp":1715282705141,"preClose":9.9,"halted":0,"volume":83376,"delay":0,"floatShares":6250000,"shares":22239333,"eps":-40.651257,"marketStatus":"交易中","marketStatusCode":2,"change":-0.74,"latestTime":"05-09 15:25:16 EDT","open":9.66,"high":10.36,"low":9.08,"amount":797091.2352,"amplitude":0.129293,"askPrice":9.21,"askSize":300,"bidPrice":9.11,"bidSize":282,"shortable":3,"etf":0,"ttmEps":-40.651257,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1715284800000},"adr":0,"listingDate":1711598400000,"adjPreClose":9.9,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":9.72,"preClose":9.9,"latestTime":"09:28 EDT","volume":202,"amount":1963.44,"timestamp":1715261280018},"volumeRatio":0.963769},"requestUrl":"/m/hq/s/BOLD","defaultTab":"news","newsList":[{"id":"2429439589","title":"Boundless Bio(BOLD.US)获Piper Sandler首次覆盖,给予增持评级, 目标价20.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2429439589","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429439589?lang=zh_cn&edition=full","pubTime":"2024-04-22 17:35","pubTimestamp":1713778524,"startTime":"0","endTime":"0","summary":"Boundless Bio(BOLD.US)获Piper Sandler首次覆盖,给予增持评级, 目标价20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221735278b4599c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221735278b4599c1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422616404","title":"肿瘤生物技术公司Boundless Bio(BOLD.US)IPO定价16美元/股 今晚登陆纳斯达克","url":"https://stock-news.laohu8.com/highlight/detail?id=2422616404","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422616404?lang=zh_cn&edition=full","pubTime":"2024-03-28 19:41","pubTimestamp":1711626113,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,开发癌基因扩增肿瘤抑制剂疗法的1期生物技术公司Boundless Bio宣布了IPO条款。该公司IPO定价为每股16美元,为15-17美元价格区间的中点,计划发行625万股股票,筹集1亿美元。该公司的普通股预计将于3月28日在纳斯达克上市交易,股票代码为“BOLD”。据了解,Boundless Bio专注于通过靶向染色体外DNA开发癌基因扩增肿瘤的治疗方法。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1095104.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422905395","title":"拜耳支持的制药商Boundless Bio通过IPO筹集1亿美元-36氪","url":"https://stock-news.laohu8.com/highlight/detail?id=2422905395","media":"界面","top":-1,"share":"https://www.laohu8.com/m/news/2422905395?lang=zh_cn&edition=full","pubTime":"2024-03-28 09:03","pubTimestamp":1711587793,"startTime":"0","endTime":"0","summary":"癌症治疗药物生产商Boundless Bio Inc.在美国进行首次公开募股,筹资1亿美元,该公司提交给美国证券交易委员会的文件显示其发行价为15至17美元。拜耳公司是该公司最大的投资者之一。(界面)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032809321487be3ba5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032809321487be3ba5&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.boundlessbio.com","stockEarnings":[{"period":"1week","weight":-0.01},{"period":"1month","weight":-0.2055},{"period":"3month","weight":-0.3812},{"period":"ytd","weight":-0.3812}],"compareEarnings":[{"period":"1week","weight":0.0337},{"period":"1month","weight":-0.0029},{"period":"3month","weight":0.0379},{"period":"6month","weight":0.1738},{"period":"1year","weight":0.2586},{"period":"ytd","weight":0.0881}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Boundless Bio, Inc.最初成立于2018年4月10日,原名Pretzel Therapeutics, Inc.,是一家特拉华州公司。2019年7月8日,公司更名为Boundless Bio, Inc.。他们是一家临床阶段的肿瘤学公司,致力于开启癌症治疗的新方式,通过靶向染色体外DNA(ecDNA)来解决癌基因扩增肿瘤患者的显著未满足需求,在超过14%的癌症患者中观察到癌基因扩增的根本原因。他们的使命是成为领先的生物制药公司,利用ecDNA生物学提供变革性的治疗方法,改善和延长患有先前难治性癌基因扩增癌的患者的生命。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.045467},{"month":2,"riseRate":0.25,"avgChangeRate":0.036219},{"month":3,"riseRate":0.666667,"avgChangeRate":0.088311},{"month":4,"riseRate":0.333333,"avgChangeRate":0.028717},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.032827},{"month":6,"riseRate":1,"avgChangeRate":0.142257},{"month":7,"riseRate":0.666667,"avgChangeRate":0.021175},{"month":8,"riseRate":0.5,"avgChangeRate":-0.031707},{"month":9,"riseRate":0.75,"avgChangeRate":0.116011},{"month":10,"riseRate":0,"avgChangeRate":-0.120737},{"month":11,"riseRate":0.75,"avgChangeRate":0.014772},{"month":12,"riseRate":0.75,"avgChangeRate":0.282026}],"exchange":"NASDAQ","name":"Boundless Bio, Inc.","nameEN":"Boundless Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Boundless Bio, Inc.(BOLD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Boundless Bio, Inc.(BOLD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Boundless Bio, Inc.,BOLD,Boundless Bio, Inc.股票,Boundless Bio, Inc.股票老虎,Boundless Bio, Inc.股票老虎国际,Boundless Bio, Inc.行情,Boundless Bio, Inc.股票行情,Boundless Bio, Inc.股价,Boundless Bio, Inc.股市,Boundless Bio, Inc.股票价格,Boundless Bio, Inc.股票交易,Boundless Bio, Inc.股票购买,Boundless Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Boundless Bio, Inc.(BOLD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Boundless Bio, Inc.(BOLD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}